PURPOSE AND OBJECTIVES
- To review the status of evidence-based recommendations for the use of different imaging modalities in the management of CVDs including SPECT, PET, echocardiography, CT and MRI;
- To review the latest advances and developments in cardiac imaging;
- To reflect on the importance and future of integrated cardiovascular imaging approaches
- To deliver supportive ‘know-how’ via continuing medical education programmes in the field, including information on the relative merits and limitations of each imaging modality;
- To reflect on the impact of COVID-19 on the diagnosis of heart conditions, and on the role of medical imaging in the assessment of cardiovascular complications due to COVID;
- To interact with all professionals involved in the management of CVDs and provide them with state-of-the-art information on cardiac imaging; and
- To identify challenges and trends, as well as the role of the IAEA and other professional organizations in addressing these.
TARGET AUDIENCE
Nuclear medicine physicians, Radiologists, Cardiologists, Radiochemists/Radiopharmacists, Medical physicists, Technologists/Radiographers, Other practitioners and scientists working in all aspects of cardiac imaging
KEY DEADLINES
|
Submission of abstracts through IAEA-INDICO |
30 April 2022 |
|
Submission of Form B (together with Form A) through the InTouch+ platform |
30 April 2022 |
|
Submission of Form C (together with Form A) through the InTouch+ platform |
30 April 2022 |
|
Notification of acceptance of abstracts for oral or poster presentation |
End of July 2022 |
|
Submission of Form A only (no paper submission, no grant request) through the InTouch+ platform |
No deadline |
